Prof Zanfina Ademi
Head, Health Economics and Policy Evaluation Research (HEPER) Group
State: VIC
Clincial areas of expertise:Cardiovascular Disease, Epilepsy, and other chronic conditions
Cost effectiveness modelling, Health policy evaluation, Health economic evaluation alongside registry-randomised trials, Trial-based economic evaluation, Economic evaluation in LMIC, Health technology assessment, Cost-benefit analysis, Budget impact analysis
Cost effectiveness modelling, Trial based economic evaluations, Productivity Adjusted Life Years
1. Ademi Z, Norman R, Pang J, Sijbrands E, Watts GF, Hutten BA, Wiegman A. Cost-effectiveness and Return on Investment of a Nationwide Case-Finding Program for Familial Hypercholesterolemia in Children in the Netherlands. JAMA Pediatr. 2023 Jun 1;177(6):625-632. doi: 10.1001/jamapediatrics.2023.0763. PMID: 37126315; PMCID: PMC10152372.
2. Baek Y, Ademi Z, Tran T, Owen A, Nguyen T, Luchters S, Hipgrave DB, Hanieh S, Tran T, Tran H, Biggs BA, Fisher J. Promoting early childhood development in Viet Nam: cost-effectiveness analysis alongside a cluster-randomised trial. Lancet Glob Health. 2023 Aug;11(8):e1269-e1276. doi: 10.1016/S2214-109X(23)00271-1. PMID: 37474233.
3. Morton JI, Marquina C, Lloyd M, Watts GF, Zoungas S, Liew D, Ademi Z. Lipid-Lowering Strategies for Primary Prevention of Coronary Heart Disease in the UK: A Cost-Effectiveness Analysis. Pharmacoeconomics. 2023 Aug 22. doi: 10.1007/s40273-023-01306-2. Epub ahead of print. PMID: 37606881.